Austonia daily newsletter—direct to your inbox 6 a.m.
×
becomeMemberIcon

become a member

(Emma Freer)

New monoclonal antibody treatments targeting people who have tested positive for COVID-19 and only just developed symptoms have been shown to reduce the severity of the disease and prevent hospitalizations.


The FDA has granted emergency use authorization for two treatments. Both are offered via IV and take about an hour to administer, plus some check-in and monitoring time. The treatments take place in a hospital or clinic setting and are meant to help neutralize the virus in patients who have already become ill.

Two pharmaceutical companies have FDA authorization for their monoclonal antibody treatments. Each has a hotline to help locate treatment providers:

  • Regeneron: 844-734-6643
  • Eli Lilly: 855-545-5921

Many area hospitals and private infusion centers are also offering monoclonal antibody treatments to COVID patients. The National Infusion Center, an Austin-based trade association, has created a locator tool, which shows 20 such sites within a 30-mile radius. But CEO Brian Nyquist cautions that many may be operating at or near capacity, given the current surge and their pre-existing, non-COVID clientele.

Additionally, Texas Gov. Greg Abbott announced the opening of a pop-up infusion center outside of the Montopolis CommUnity Care location earlier this month. Area hospital systems have donated Regeneron supplies to ensure steady—and free—treatment remains available.

One week into its operations, the center is treating around 26 COVID patients each day. Patients must be referred by area physicians or contacted by Austin Public Health and CommUnity Care after receiving a positive test result for COVID at one of their sites.

Although the center is ramping up its capacity, with a goal of treating 75 patients each day, demand will likely continue to outpace supply, similar to the vaccine rollout. "With uncontrolled spread throughout the community, we expect to keep seeing high demand," EMS System Deputy Medical Director Dr. Jason Pickett said Wednesday.

Because the drugs remain under an emergency use authorization, it is given only to priority patients, including those populations at highest risk of being hospitalized with—or dying from—COVID. These include the elderly, communities of color and those without insurance.

State and local officials say monoclonal antibody treatments are an important tool to help reduce hospitalizations, especially as ICUs across the Austin metro near capacity.


More on COVID:

Updated: Want to be added to a vaccine waitlist? Here's where to sign up


Popular

Even with million-dollar campaigns, voters aren't going to the polls to vote on the controversial bill Prop A. (Austonia)

Both Prop A advocates Save Austin Now and opponents political action committee Equity PAC raised over $1 million in funding between Sept. 24 and Oct. 23 ahead of Austin's Nov. 2 election, but their efforts haven't yet been reflected in the polls.

Keep Reading Show less
The Oakwood Cemetery is said to have souls roaming around. (Steven Joyner/Austonia)

As Halloween makes us second guess if that cold spot was a ghost or simply the cool front, keep your guard up because there are supposed haunted grounds in the city.

Keep Reading Show less

Luxury car condos are in the works at Circuit of the Americas. (Lincoln Property Company)

Coming off of the heels of the biggest Formula 1 race to date, Circuit of the Americas now has plans to create luxury "car condos" for racecar enthusiasts right by the track.

Keep Reading Show less